How do you keep weight off after stopping tirzepatide?

The Regain Data

SURMOUNT-4 randomized tirzepatide 10 mg responders (after 36 weeks) into continue vs placebo groups for another 52 weeks:

• Continue group: lost an additional 5.5% body weight
• Placebo group: regained 14.0% body weight (net effect difference of 19.5%)

Interpretation: stopping tirzepatide without plan regains most of what you lost within a year. Regain is primarily driven by returned appetite and higher food intake.

Why Regain Happens — It's Not a "Metabolic Rebound"

The popular narrative is that GLP-1 drugs "damage metabolism" and cause regain. The accurate picture:

• BMR drops after weight loss (~200–400 kcal/day on a 50+ lb loss) — this is normal for any weight loss, drug or not
• Appetite returns fully within 6–8 weeks of stopping
• Food intake often exceeds pre-drug baseline for a period
• Net: caloric intake > expenditure, weight regains

The fix is managing appetite and intake after stopping — which is harder than with the drug, but not biologically impossible.

Step 1: Taper, Don't Stop

Cold-stopping tirzepatide 15 mg is the worst protocol. Taper protocol:

• Hold current dose for 2+ months after reaching goal weight
• 15 → 12.5 mg for 4 weeks
• 12.5 → 10 mg for 4 weeks
• 10 → 7.5 mg for 4 weeks
• 7.5 → 5 mg for 4 weeks
• 5 → 2.5 mg for 4 weeks
• 2.5 mg → stop, or consider maintaining at 2.5 mg indefinitely

Total taper: 5 months. Each step gives you time to adjust behaviorally before appetite rises further.

Step 2: Build Food Habits BEFORE the Taper

Start 3+ months before planned taper:

Track food intake

• Log every meal — use MyFitnessPal, Cronometer, or similar
• Goal isn't perfection; goal is awareness of your actual intake
• Know your approximate maintenance kcal at current weight

Establish protein target

• 1.4+ g/kg body weight/day
• Build it into routine meals, not via daily novelty

Build "no-think" default meals

• 3–5 meals you can prepare without decision-making
• These become your fallback when appetite returns and decision fatigue hits

Identify your trigger foods and environments

• What did you overeat pre-drug? Those patterns return
• Environmental tweaks reduce risk: don't keep trigger foods at home

Step 3: Lock In Resistance Training

• 3× per week, minimum 3 months established before tapering
• Protects muscle during loss AND raises maintenance TDEE
• Lost muscle = lower BMR = harder to maintain weight

Step 4: Daily Weighing + Weekly Trend

• Daily weight, weekly average
• Set your "trigger weight" — 3–5 lbs above your new maintenance weight
• Hitting trigger weight = immediate action, not "next week"

Step 5: Have a Restart Plan Ready

Decide in advance:

• What weight triggers drug restart? (Typically 8–10% of body weight regained)
• What dose will you restart at? (Usually not all the way back to max — often mid-dose)
• What's your provider relationship? Can you get a script within a week if needed?

Having the plan ready prevents the slow drift that makes 5% regain become 15%.

Alternative: Low-Dose Maintenance Instead of Stopping

Many patients get better outcomes by staying on low-dose tirzepatide (2.5 mg weekly) indefinitely rather than stopping entirely:

• Cheaper than full dose
• Lower side effect burden than therapeutic dose
• Much lower regain risk than cold stop
• No cumulative trial data beyond 2–3 years, but also no specific safety signals

Discuss with your provider whether indefinite maintenance is appropriate before committing to stopping.

The First 90 Days Off Are Critical

Highest-risk regain period is weeks 4–16 after full cessation:

• Appetite is fully returned
• Food novelty/interest returns
• Habits haven't consolidated yet
• Drug protection is gone

Plan extra rigor for this window: tracked food, scheduled exercise, weigh-ins every day.

When to Restart

Consider restarting tirzepatide if:

• Regain > 5% of body weight within 6 months
• Weekly average weight rising consistently over 8+ weeks
• Food habits breaking down despite effort
• Significant quality-of-life decline from food preoccupation

Restarting isn't failure. Obesity is a chronic condition; GLP-1 drugs are chronic therapy. The "courage to stop" framing isn't always the right one.

Bottom Line

Keeping weight off after stopping tirzepatide is possible but requires deliberate habit-building before the taper. The evidence favors long-term low-dose maintenance over full cessation for most patients. If you do stop, taper slowly, track rigorously, and have a restart plan ready.

See the tirzepatide guide. Related: plateau, vs semaglutide.